Heads up: some links below are affiliate links — assume any provider we list may compensate us, at no cost to you. It never buys a better score, but the providers we work with are listed first. See our affiliate disclosure.
Head-to-head
CoreAge Rx vs Vyvron
CoreAge Rx and Vyvron both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.
CoreAge Rx
Higher scoreRanked #1 · Grade A
Best for: Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Visit CoreAge RxVyvron
Ranked #247 · Grade C
Best for: A parent who wants the billing period stated so the annual figure is exact, and can accept a seller with no legal documents.
Visit VyvronThe verdict
CoreAge Rx edges out Vyvron on the Rx-Readiness Score, 95 to 49 (A vs C). Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Vyvron is still a genuine option — the billing cycle is stated in the same sentence as the price, so the year is countable without guesswork: thirteen charges of $149 is $1,937 for semaglutide and $2,587 for tirzepatide. Both are founding rates the site says will rise to $179 and $249 — $2,327 and $3,237 a year. What you cannot read is any of its legal documents, because they are the homepage with a different title on the tab. Weigh the six readiness factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | CoreAge Rx | Vyvron |
|---|---|---|
| Rx-Readiness Score | 95/100 · A | 49/100 · C |
| Overall rank | #1 | #247 |
| Semaglutide | $99/mo | $149 per 4 weeks |
| Tirzepatide | $149/mo | $199 per 4 weeks |
| Coverage | All 50 states | Not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
CoreAge Rx
Ranked #1 · Grade A
What we like
- Flat monthly price that stays put through titration — no dose-scaling surprise on your busiest month
- Both compounded semaglutide and tirzepatide on one plan, so you're not re-signing to switch
- Async, no-video intake and all-50-states coverage — start it during a lunch break
The caveats
- Not the rock-bottom sticker price — a couple of teaser tiers elsewhere start lower
- Compounded only — no FDA-approved brand option
- General metabolic program, not a boutique concierge service
Vyvron
Ranked #247 · Grade C
What we like
- States the four-week cycle beside the price, so thirteen charges a year is obvious rather than discovered
- Discloses auto-renewal in the same sentence
- Both molecules priced separately at $149 and $199 per four weeks
The caveats
- Terms, privacy and shipping policy do not exist — each URL returns the homepage under a legal title
- Thirteen charges a year is 8% more than a monthly reading of the same figure
- Both rates are founding prices the site says will rise
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and Vyvron against other providers on our shortlist.
Or browse the full comparison hub.